FIGURE 2—

Effects of eicosapentaenoic acid treatment on the incidence of major coronary events for (a) the primary prevention total population, (b) the primary prevention high triglyceride and low high-density lipoprotein subgroup, and (c) the primary and secondary prevention impaired glucose metabolism subgroups: the Japan EPA Intervention Lipid Study.

Note. IGM = impaired glucose metabolism; NG = normoglycemia. Hazard ratios were (a) 0.82 (95% confidence interval [CI] = 0.63, 1.06; P = .132), (b) 0.47 (95% CI = 0.23, 0.98; P = .043), and (c) 0.78 (95% CI = 0.60, 0.998; P = .048) for IGM and 0.82 (95% CI = 0.66, 1.01; P = .062) for NG.

Source. Yokoyama et al.^26-28